I. Rubino

Patient and parent oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in SMA. Rome, 13 July 2019

R. Finkel, M. Schroth, A. Mayhew, 2020, Neuromuscular Disorders.

Diagnosis of Early Alzheimer’s Disease: Clinical Practice in 2021

M. Sabbagh, R. Isaacson, A. Porsteinsson, 2021, The Journal of Prevention of Alzheimer's Disease.

Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer’s Disease Treated with Anti-Amyloid Beta Therapy

J. Suhy, J. Barakos, S. Chalkias, 2022, The Journal of Prevention of Alzheimer's Disease.

Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient Management

M. Sabbagh, P. Aisen, J. Langbaum, 2021, Frontiers in Neurology.

Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: an updated instrumental variable meta-analysis

Robert W. Platt, Chunhua Shen, A. Gabelle, 2022, medRxiv.

Economic and caregiver impact of Alzheimer’s disease across the disease spectrum: a cohort study

P. Krolak-Salmon, M. Potashman, V. Dauphinot, 2022, Alzheimer's research & therapy.

Assessing what matters most to patients with or at risk for Alzheimer’s and care partners: a qualitative study evaluating symptoms, impacts, and outcomes

L. Callahan, H. Krasa, S. Wronski, 2020, Alzheimer's Research & Therapy.

Toward the end of a controversy on the effect of reduction in brain amyloid levels on change in cognitive and functional decline in Alzheimer's disease—Reply to a letter

Robert W. Platt, Chunhua Shen, A. Gabelle, 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: An instrumental variable meta‐analysis

Robert W. Platt, Chunhua Shen, A. Gabelle, 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.